Modulatory role of serotonin on feeding behavior

Nutritional Neuroscience

Volumn 13, Issue 6, 2010, Pages 246-255

  Magalhães, Carolina Peixoto ^a   De Freitas, Manuela Figueiroa Lyra ^a   Nogueira, Maria Inês ^b   Campina, Renata Cristinny De Farias ^a   Takase, Luiz Fernando ^c   De Souza, Sandra Lopes ^a   De Castro, Raul Manhães ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

feeding behavior; serotonergic receptors; serotonergic system

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; CHOLECYSTOKININ; DEVAZEPIDE; FLUOXETINE; LEPTIN; LORCASERIN; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTRANSMITTER; PROOPIOMELANOCORTIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST;

ANATOMICAL VARIATION; ANOREXIA; APPETITE; BODY WEIGHT; DRUG ABSORPTION; EMOTION; ENERGY BALANCE; ENERGY METABOLISM; FEEDING BEHAVIOR; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPOPHAGIA; HYPOTHALAMUS; LOCOMOTION; LOW DRUG DOSE; METABOLIC RATE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SATIETY; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; THALAMUS MIDLINE NUCLEUS; WEIGHT REDUCTION;

ANIMALS; CHOLECYSTOKININ; ENERGY METABOLISM; FEEDING BEHAVIOR; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; NEURONS; NEUROPEPTIDE Y; PRO-OPIOMELANOCORTIN; RECEPTORS, SEROTONIN; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 78049491672     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683010X12611460764723     Document Type: Review

References (136)

1. Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med 2000;32:222-232.
2. Chandler-Laney PC, Castaneda E, Viana JB, Oswald KD, Maldonado CR, Boggiano M. A history of human-like dieting alters serotonergic control of feeding and neurochemical balance in a rat model of binge-eating. Int J Eat Disord 2007;40:136-142.
3. Consolo S, Garattini S, Ghielmetti R, Morselli P, Valzelli L. The hydroxylation of tryptophan in vivo by brain. Life Sci 1965;4:625-630.
4. Tecott LH. Serotonin and the orchestration of energy balance. Cell Metab 2007;6:352-361.
5. Breisch ST, Zemlan FP, Hoebel BG. Hyperphagia and obesity following serotonin depletion by intraventricular pchlorophenylalanine. Science 1976;192:382-385.
6. Saller CF, Stricker EM. Hyperphagia and increased growth in rats after intraventricular injection of 5, 7-dihydroxytryptamine. Science 1976;192:385-387.
7. Guy-Grand B. Clinical studies with dexfenfluramine: from past to future. Obes Res 1995;3(Suppl 4):491S-496S.
8. Simansky KJ, Vaidya AH. Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res Bull 1990;25:953-960.
9. Heisler LK, Kanarek RB, Gerstein A. Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats. Pharmacol Biochem Behav 1997;58:767-773.
10. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 1997;121:1758-1762.
11. Wynne K, Park AJ, Small CJ et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a doubleblind, randomized, controlled trial. Diabetes 2005;54:2390-2395.
12. Morton DP, Aragon-Vargas LF, Callister R. Effect of ingested fluid composition on exercise-related transient abdominal pain. Int J Sport Nutr Exerc Metab 2004;14:197-208.
13. Molliver ME. Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 1987;7(Suppl): 3S-23S.
14. Heisler LK, Jobst EE, Sutton GM et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 2006;51:239-249.
15. Li BH, Rowland NE. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull 1993;31:43-48.
16. Rowland NE, Mukherjee M, Robertson K. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 2001;159:111-116.
17. Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK. Role of central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab 2009;20:203-215.
18. Grill HJ, Donahey JC, King L, Kaplan JM. Contribution of caudal brainstem to d-fenfluramine anorexia. Psychopharmacology (Berl) 1997;130:375-381.
19. Kaplan JM, Song S, Grill HJ. Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP. Psychopharmacology (Berl) 1998;137:43-49.
20. Lam DD, Przydzial MJ, Ridley SH et al. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 2008;149:1323-1328.
21. Garfield AS, Heisler LK. Pharmacological targeting of the serotonergic system for the treatment of obesity. J Physiol 2009;587:49-60.
22. -/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. J Endocrinol 2006;190:515-525.
23. Huszar D, Lynch CA, Fairchild-Huntress V et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
24. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992;71:1195-1204.
25. Heisler LK, Cowley MA, Tecott LH et al. Activation of central melanocortin pathways by fenfluramine. Science 2002;297:609-611.
26. Bovetto S, Rouillard C, Richard D. Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate. Am J Physiol 1996;271: R1231-R1238.
27. Javed A, Kamradt MC, Van de Kar LD, Gray TS. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropinreleasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala. Neuroscience 1999;90:851-858.
28. Hutson PH, Donohoe TP, Curzon G. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology (Berl) 1988;95:550-552.
29. Shor-Posner G, Azar AP, Jhanwar-Uniyal M, Filart R, Leibowitz SF. Destruction of noradrenergic innervation to the paraventricular nucleus: deficits in food intake, macronutrient selection, and compensatory eating after food deprivation. Pharmacol Biochem Behav 1986;25:381-392.
30. Gibbs J, Smith GP, Kirkham TO. Gastrin-releasing peptide and satiety. Gastroenterology 1994;106:1374-1376.
31. Sodersten P, Forsberg G, Bednar I, Lindén A, Qureshi GA. Cholecystokinin in the control of ingestive behavior. Prog Brain Res 1992;92:335-343.
32. Stallone D, Nicolaidis S, Gibbs J. Cholecystokinin-induced anorexia depends on serotoninergic function. Am J Physiol 1989;256: R1138-R1141.
33. Hughes J, Boden P, Costall B et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 1990;87:6728-6732.
34. Cooper SJ, Dourish CT. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. Physiol Behav 1990;48:849-857.
35. Daughters RS, Hofbauer RD, Grossman AW et al. Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla. Peptides 2001;22:1331-1338.
36. Hayes MR, Savastano DM, Covasa M. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors. Physiol Behav 2004;82:663-669.
37. Doucet E, Miquel MC, Nosjean A, Vergé D, Hamon M, Emerit MB. Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor. Neuroscience 2000;95:881-892.
38. 3H]zacopride as radioligands. Synapse 1992;10:271-281.
39. Hung C Y, Covasa M, Ritter RC, Burns GA. Hindbrain administration of NMDA receptor antagonist AP-5 increases food intake in the rat. Am J Physiol 2006;290: R642-R651.
40. Cooper SJ, Barber DJ. SCH 23390-induced hypophagia is blocked by the selective CCK-A receptor antagonist devazepide, but not by the CCK-B/gastrin receptor antagonist L-365, 260. Brain Res Bull 1990;24:631-633.
41. Czachowski CL. Manipulations of serotonin function in the nucleus accumbens core produce differential effects on ethanol and sucrose seeking and intake. Alcohol Clin Exp Res 2005;29:1146-1155.
42. Pratt WE, Blackstone K. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking. Behav Brain Res 2009;198:252-257.
43. Jean A, Conductier G, Manrique C et al. Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proc Natl Acad Sci USA 2007;104:16335-16340.
44. Lidov HG, Molliver ME. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull 1982;8:389-430.
45. Audet MA, Descarries L, Doucet G. Quantified regional and laminar distribution of the serotonin innervation in the anterior half of adult rat cerebral cortex. J Chem Neuroanat 1989;2:29-44.
46. Turlejski K. Evolutionary ancient roles of serotonin: long-lasting regulation of activity and development. Acta Neurobiol Exp (Wars) 1996;56:619-636.
47. Parent A. Comparative anatomy of the serotoninergic systems. J Physiol (Paris) 1981;77:147-156.
48. Dahlstroem A, Fuxe K. Evidence for the existence of monoaminecontaining neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl 1964;232:1-55.
49. Steinbusch H W, Nieuwenhuys R, Verhofstad AA, Van der Kooy D. The nucleus raphe dorsalis of the rat and its projection upon the caudatoputamen. A combined cytoarchitectonic, immunohistochemical and retrograde transport study. J Physiol (Paris) 1981;77:157-174.
50. Halliday GM, Tork I. Electron microscopic analysis of the mesencephalic ventromedial tegmentum in the cat. J Comp Neurol 1984;230:393-412.
51. Weissmann D, Belin MF, Aguera M et al. Immunohistochemistry of tryptophan hydroxylase in the rat brain. Neuroscience 1987;23:291-304.
52. Azmitia EC, Gannon PJ. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol 1986;43:407-468.
53. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978;179:641-667.
54. Davidowa H, Plagemann A. Decreased inhibition by leptin of hypothalamic arcuate neurons in neonatally overfed young rats. Neuroreport 2000;11:2795-2798.
55. Pusztai P, Somogyi A, Racz K, Tulassay Z. [Ghrelin: a new peptide regulating the neurohormonal system and energy homeostasis]. Orv Hetil 2004;145:2569-253.
56. Kalra SP, Ueno N, Kalra PS. Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action. J Nutr 2005;135:1331-1335.
57. Kishi T, Elmquist JK. Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry 2005;10:132-146.
58. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100.
59. Tempel DL, Shor-Posner G, Dwyer D, Leibowitz SF. Nocturnal patterns of macronutrient intake in freely feeding and food-deprived rats. Am J Physiol 1989;256: R541-R548.
60. Horvath TL, Leranth C, Kalra SP, Naftolin F. Galanin neurons exhibit estrogen receptor immunoreactivity in the female rat mediobasal hypothalamus. Brain Res 1995;675:321-324.
61. Horvath TL, Naftolin F, Leranth C, Sahu A, Kalra SP. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 1996;137:3069-3078.
62. Levin BE, Dunn-Meynell AA. Defense of body weight against chronic caloric restriction in obesity-prone and-resistant rats. Am J Physiol 2000;278: R231-R237.
63. Plagemann A, Harder T, Rake A et al. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res 1999;836:146-155.
64. Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav, 2007;92:263-271.
65. Brobeck JR, Larsson S, Reyes E. A study of the electrical activity of the hypothalamic feeding mechanism. J Physiol 1956;132:358-364.
66. Anand BK, Brobeck JR. Localization of a 'feeding center' in the hypothalamus of the rat. Proc Soc Exp Biol Med 1951;77:323-324.
67. Beck B. Neuropeptides and obesity. Nutrition 2000;16:916-923.
68. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998;44:851-864.
69. van den Pol AN. Weighing the role of hypothalamic feeding neurotransmitters. Neuron 2003;40:1059-1061.
70. Seeley RJ, Drazen DL, Clegg DJ. The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr 2004;24:133-149.
71. Rapport MM, Green AA, Page IH. Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem 1948;176:1243-1251.
72. Rapport MM, Green AA, Page IH. Crystalline serotonin. Science 1948;108:329-330.
73. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
74. Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. J Endocrinol 2005;184:291-318.
75. Broberger C, Landry M, Wong H, Walsh JN, Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997;66:393-408.
76. Baskin DG, Hahn TM, Schwartz MW. Leptin sensitive neurons in the hypothalamus. Horm Metab Res 1999;31:345-350.
77. Densmore VS, Morton NM, Mullins JJ, Seckl JR. 11 betahydroxysteroid dehydrogenase type 1 induction in the arcuate nucleus by high-fat feeding: a novel constraint to hyperphagia? Endocrinology 2006;147:4486-4495.
78. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991;88:10931-10935.
79. Swart I, Jahng J W, Overton JM, Houpt TA. Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice. Am J Physiol 2002;283: R1020-R1026.
80. Sanacora G, Kershaw M, Finkelstein JA, White JD. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990;127:730-737.
81. Gayle D, Ilyin SE, Plata-Salaman CR. Feeding status and bacterial LPS-induced cytokine and neuropeptide gene expression in hypothalamus. Am J Physiol 1999;277: R1188-R1195.
82. Orozco-Solis R, Lopes de Souza S, Barbosa Matos RJ et al. Perinatal undernutrition-induced obesity is independent of the developmental programming of feeding. Physiol Behav 2009;96:481-492.
83. Ballinger AB, Williams G, Corder R, El-Haj T, Farthing MJ. Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat. Clin Sci (Lond) 2001;100:221-229.
84. Ohliger-Frerking P, Horwitz BA, Horowitz JM. Serotonergic dorsal raphe neurons from obese Zucker rats are hyperexcitable. Neuroscience 2003;120:627-634.
85. Christophe J. Is there appetite after GLP-1 and PACAP? Ann NY Acad Sci 1998;865:323-335.
86. Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 1999;31:6-41.
87. Mogenson GJ, Jones DL, Yim CY. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980;14:69-97.
88. Kelly JF, Elias CF, Lee CE et al. Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain. Diabetes 2004;53:911-920.
89. Will MJ, Franzblau EB, Kelley AE. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003;23:2882-2888.
90. Travers JB, Travers SP, Norgren R. Gustatory neural processing in the hindbrain. Annu Rev Neurosci 1987;10:595-632.
91. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-1308.
92. Mercer JG, Moar KM, Hoggard N. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology 1998;139:29-34.
93. Rogers RC, Hermann GE. Vagal afferent stimulation-evoked gastric secretion suppressed by paraventricular nucleus lesion. J Auton Nerv Syst 1985;13:191-199.
94. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006;311:230-232.
95. Rosenzweig-Lipson S, Zhang J, Mazandarani H et al. Antiobesitylike effects of the 5-HT2C receptor agonist WAY-161503. Brain Res 2006;1073/1074:240-251.
96. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
97. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-554.
98. Filip M. Role of serotonin (5-HT) 2 receptors in cocaine selfadministration and seeking behavior in rats. Pharmacol Rep 2005;57:35-46.
99. Gur E, Newman ME, Avraham Y, Dremencov E, Berry EM. The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats. Nutr Neurosci 2003;6:169-175.
100. Simansky KJ, Nicklous DM. Parabrachial infusion of D-fenfluramine reduces food intake. Blockade by the 5-HT (1B) antagonist SB-216641. Pharmacol Biochem Behav 2002;71:681-690.
101. Park S, Harrold JA, Widdowson PS, Williams G. Increased binding at 5-HT (1A), 5-HT (1B), and 5-HT (2A) receptors and 5-HT transporters in diet-induced obese rats. Brain Res 1999;847:90-97.
102. Hewitt KN, Lee MD, Dourish CT, Clifton PG. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol Biochem Behav 2002;71:691-700.
103. Bickerdike MJ. 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Top Med Chem 2003;3:885-897.
104. Kennett GA, Trail B, Bright F. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Neuropharmacology 1998;37:1603-1610.
105. Dourish CT. Multiple serotonin receptors: opportunities for new treatments for obesity? Obes Res 1995;3(Suppl 4):449S-462S.
106. Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999;21(Suppl): 52S-60S.
107. Leibowitz SF, Weiss GF, Walsh UA, Viswanath D. Medial hypothalamic serotonin: role in circadian patterns of feeding and macronutrient selection. Brain Res 1989;503:132-140.
108. De Vry J, Schreiber R. Effects of selected serotonin 5-HT (1) and 5-HT (2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev 2000;24:341-353.
109. Lee MD, Kennett GA, Dourish CT, Clifton PG. 5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94, 253. Psychopharmacology (Berl) 2002;164:49-60.
110. Halford JC, Blundell JE. The 5-HT1B receptor agonist CP-94, 253 reduces food intake and preserves the behavioural satiety sequence. Physiol Behav 1996;60:933-939.
111. Lee MD, Somerville EM, Kennett GA, Dourish CT, Clifton PG. Tonic regulation of satiety by 5-HT receptors in the mouse: converging evidence from behavioural and c-fos immunoreactivity studies? Eur J Neurosci 2004;19:3017-3025.
112. Lee MD, Simansky KJ. CP-94, 253: a selective serotonin1B (5-HT1B) agonist that promotes satiety. Psychopharmacology (Berl) 1997;131:264-270.
113. Lee MD, Clifton PG. Free-feeding and free-drinking patterns of male rats following treatment with opiate kappa agonists. Physiol Behav 1992;52:1179-1185.
114. Schreiber R, Manze B, Haussels A, De Vry J. Effects of the 5-HT1A receptor agonist ipsapirone on operant self-administration of ethanol in the rat. Eur Neuropsychopharmacol 1999;10:37-42.
115. Currie PJ, Coiro CD, Niyomchai T, Lira A, Farahmand F. Hypothalamic paraventricular 5-hydroxytryptamine: receptorspecific inhibition of NPY-stimulated eating and energy metabolism. Pharmacol Biochem Behav 2002;71:709-716.
116. Kennett GA, Dourish CT, Curzon G. 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 1987;141:429-435.
117. Lee MD, Aloyo VJ, Fluharty SJ, Simansky KJ. Infusion of the serotonin1B (5-HT1B) agonist CP-93, 129 into the parabrachial nucleus potently and selectively reduces food intake in rats. Psychopharmacology (Berl) 1998;136:304-307.
118. Abramowski D, Rigo M, Duc D, Hoyer D, Staufenbiel M. Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 1995;34:1635-1645.
119. Nonogaki K, Abdallah L, Goulding EH, Bonasera SJ, Tecott LH. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT (2C) receptor mutant mice. Diabetes 2003;52:315-320.
120. Tecott LH, Sun LM, Akana SF et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995;374:542-546.
121. Conn PJ, Sanders-Bush E. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site. J Neurosci 1986;6:3669-3675.
122. Julius D, MacDermott AB, Jessel TM et al. Functional expression of the 5-HT1c receptor in neuronal and nonneuronal cells. Cold Spring Harb Symp Quant Biol 1988;53:385-393.
123. Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 1995;351:357-373.
124. Clifton PG, Lee MD, Dourish CT. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl) 2000;152:256-267.
125. Yamada J, Sugimoto Y, Hirose H, Kajiwara Y. Role of serotonergic mechanisms in leptin-induced suppression of milk intake in mice. Neurosci Lett 2003;348:195-197.
126. McCreary AC, Filip M, Cunningham KA. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes. Behav Neurosci 2003;117:212-221.
127. Vickers SP, Clifton PG, Dourish CT, Tecott LH. Reduced satiating effect of d-fenfluramine in serotonin 5-HT (2C) receptor mutant mice. Psychopharmacology (Berl) 1999;143:309-314.
128. Gluck T, Silver J, Epstein M, Cao P, Farber B, Goyert SM. Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur J Med Res 2001;6:351-358.
129. Thomsen WJ, Grottick AJ, Menzaghi F et al. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 2008;325:577-587.
130. Kennett GA, Curzon G. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 1988;94:137-147.
131. Dourish CT, Clark ML, Fletcher A, Iversen SD. Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats. Psychopharmacology (Berl) 1989;97:54-58.
132. Blundell JE, Hill AJ. Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. Int J Obes 1987;11(Suppl 3):141-155.
133. Blundell JE. Serotonin and appetite. Neuropharmacology 1984;23:1537-1551.
134. Curzon G. Serotonin and appetite. Ann NY Acad Sci 1990;600:521-530, discussion 530-531.
135. Halford JC, Lawton CL, Blundell JE. The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence. Pharmacol Biochem Behav 1997;56:41-46.
136. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289-295.